Accuray earnings release, August 19, 2026

Accuray Inc (ARAY) · Form 8-K, Item 2.02 · Filed · SEC filing

Accuray Reports Fourth Quarter and Fiscal

2026

Financial Results

MADISON, Wisconsin, August 19, 2026 — Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal

2026, ended

June 30, 2026.

Key Highlights

“Fiscal 2026 was a transformational year for Accuray. Throughout the year, we strengthened our operational foundation, improved accountability and execution, expanded our ecosystem of strategic partnerships, advanced differentiated technology capabilities, and took important steps to enhance our financial position,” said Steve LaNeve, President and Chief Executive Officer. “Despite ongoing geopolitical uncertainty, tariff pressures, and market volatility, we remained focused on the factors within our control and successfully executed against the transformation initiatives we introduced earlier in the fiscal year. As a result, Accuray enters fiscal 2027 as a stronger company with greater financial flexibility, and a clear focus on driving sustainable revenue growth, margin expansion, and long-term shareholder value.”

Fiscal Fourth Quarter Results

Total net revenue was

$100.9 million for the fourth quarter of fiscal

2026, or a decrease of²¹ percent, as compared to

$127.5 million in the prior fiscal year fourth quarter. Product revenue totaled

$40.8 million, or a decrease of⁴² percent, as compared to

$70.7 million in the prior fiscal year fourth quarter, while service revenue totaled

$60.1 million, or an increase of⁶ percent, as compared to

$56.8 million in the prior fiscal year fourth quarter.

Total gross profit in the fourth quarter of fiscal

2026 was

$35.1 million, or

34.8 percent of net revenue, as compared to total gross profit of

$39.0 million, or

30.6 percent of net revenue in the prior fiscal year fourth quarter.

Operating expenses were

$29.6 million in the fourth quarter of fiscal

2026, or a decrease of¹⁵ percent, as compared to

$34.7 million in the prior fiscal year fourth quarter. Operating expenses in the fourth quarter of fiscal 2026 include

$0.7 million of restructuring charges. Excluding restructuring charges, operating expenses would have decreased by

$5.9 million or¹⁷ percent, as compared to the prior fiscal year fourth quarter.

Net loss was

$1.9 million, or

$0.02 per share, in the fourth quarter of fiscal

2026, as compared to a net income of

$1.1 million, or

$0.01 per share, in the prior fiscal year fourth quarter. Adjusted EBITDA was

$12.9 million in the fourth quarter of fiscal

2026 compared to

$9.4 million in the prior fiscal year fourth quarter.

Gross product orders were

$37.7 million in the fourth quarter of fiscal 2026 as compared to

$84.7 million in the prior fiscal year fourth quarter. The book to bill ratio was

0.9 in the fourth quarter of fiscal 2026, as compared to

1.2 in the prior fiscal year fourth quarter. Order backlog as of June 30, 2026, was

$312.5 million, approximately²⁷ percent lower than the end of the prior fiscal year fourth quarter.

Total cash, cash equivalents, and short-term restricted cash were

$41.2 million as of

June 30, 2026, an increase of

$2.7 million from

March 31, 2026.

Fiscal Year

2026

Highlights

Total net revenue was

$401.9 million for fiscal

2026, or a decrease of¹² percent, as compared to

$458.5 million in the prior fiscal year period. Product revenue totaled

$172.7 million, or a decrease of²⁷ percent, as compared to

$237.6 million in the prior fiscal year period. Service revenue totaled

$229.2 million, or an increase of⁴ percent, as compared to

$220.9 million in the prior fiscal year period.

Total gross profit was

$111.5 million for fiscal

2026, or

27.7 percent of net revenue, as compared to total gross profit of

$147.0 million, or

32.1 percent of net revenue in the prior fiscal year period.

Operating expenses were

$137.9 million for fiscal

2026, or a decrease of¹ percent, as compared to

$139.1 million for the prior fiscal year period. Operating expenses in fiscal 2026 include

$16.2 million of restructuring charges. Excluding restructuring charges, operating expenses would have decreased by

$17.4 million or¹³ percent, as compared to the prior fiscal year.

GAAP net loss was

$49.2 million, or

$0.40 per share, for the fiscal

2026, as compared to a net loss of

$1.6 million, or

$0.02 per share, in the prior fiscal year period. Adjusted EBITDA was

$10.6 million for fiscal

2026, as compared to

$28.3 million in the prior fiscal year period.

Gross product orders were

$191.9 million for fiscal 2026 as compared to

$288.0 million for the prior fiscal year period. The book to bill ratio was

1.1 in fiscal 2026, as compared to

1.2 in the prior fiscal year.

“Fiscal 2026 was a year of meaningful operational and structural change,” said Ali Pervaiz, Chief Financial Officer. “While product demand in certain regions remained impacted by geopolitical developments and tariff uncertainty, we continued to expand service revenue, improve operating efficiency, and execute our transformation initiatives ahead of expectations. We also announced a comprehensive transaction that enhances liquidity and reduces leverage as we enter the next phase of Accuray’s transformation.”

Fiscal Year

2027

Financial Guidance... (truncated)ncies.

Given ongoing uncertainty related to geopolitical developments, international trade policy, tariff impacts, conditions in China and the Middle East, and broader macroeconomic factors, the Company is not providing formal revenue or Adjusted EBITDA guidance for fiscal 2027 at this time. Management believes the actions taken during fiscal 2026 have strengthened the business and improved the Company’s ability to execute and create long-term value for shareholders.

Conference Call Information

Accuray will host a conference call beginning at 3:30 p.m. CT/4:30 p.m. ET today to discuss results for the fourth quarter of fiscal 2026 as well as recent corporate developments. Conference call dial-in information is as follows:

Individuals interested in listening to the live conference call via the Internet may do so by logging on to the Investor Relations section of Accuray’s website, www.accuray.com. There will be a slide presentation accompanying today’s event which can also be accessed on the company’s Investor Relations page at www.accuray.com.

In addition, a taped replay of the conference call will be available beginning approximately one hour after the call’s conclusion and will be available for seven days. The replay number is (877) 344-7529 (USA), or (412) 317-0088 (International), Conference ID: 3326908. An archived webcast will also be available on Accuray’s website until Accuray announces its results for the first quarter of fiscal 2027.

Use of Non-GAAP Financial Measures

Accuray reports its financial results in accordance with generally accepted accounting principles in the United States (“GAAP”) and the rules of the SEC. To supplement its financial statements prepared and presented in accordance with GAAP, Accuray uses certain non-GAAP financial measures, such as Adjusted EBITDA.

Accuray has supplemented its GAAP net income (loss) with a non-GAAP measure of Adjusted earnings before interest, taxes, depreciation, amortization, stock-based compensation, changes to the fair value of warrant liability, and restructuring charges (“Adjusted EBITDA”). The calculation of Adjusted EBITDA also excludes certain non-recurring, irregular and one-time items. Management believes that this non-GAAP financial measure provides useful supplemental information to management and investors regarding the performance of the company and facilitates a meaningful comparison of results for current periods with previous operating results. A reconciliation of GAAP net income (loss) (the most directly comparable GAAP measure) to non-GAAP Adjusted EBITDA is provided in the schedules below.

There are limitations in using these non-GAAP financial measures because they are not prepared in accordance with GAAP and may be different from non-GAAP financial measures used by other companies. These non-GAAP financial measures should not be considered in isolation or as a substitute for GAAP financial measures. Investors and potential investors should consider non-GAAP financial measures only in conjunction with the company’s consolidated financial statements prepared in accordance with GAAP.

About Accuray

Accuray Incorporated (Nasdaq: ARAY) is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions that are designed to deliver radiation treatments for even the most complex cases—while making commonly treatable cases even easier—to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in Madison, Wisconsin, with facilities worldwide.

Safe Harbor Statement

Financial statements

Income Statement

Three Months Ended June 30, — (Unaudited) (in thousands)

Three Months Ended June 30, – 2026Three Months Ended June 30, – 2025Twelve Months Ended June 30, – 2026Twelve Months Ended June 30, – 2025
Net revenue:Products40,83270,702172,712237,580
Net revenue:Services60,08756,841229,235220,925
Net revenue:Total net revenue100,919127,543401,947458,505
Cost of revenue:Cost of products27,89551,254132,297162,569
Cost of revenue:Cost of services37,94737,310158,196148,969
Cost of revenue:Total cost of revenue65,84288,564290,493311,538
Cost of revenue:Gross profit35,07738,979111,454146,967
Operating expenses:Research and development7,70711,47037,75347,942
Operating expenses:Selling and marketing9,58711,40938,57343,315
Operating expenses:General and administrative11,51211,86645,39847,871
Operating expenses:Restructuring74716,172
Operating expenses:Total operating expenses29,55334,745137,896139,128
Operating expenses:Income (loss) from operations5,5244,234-26,4427,839
Operating expenses:(Loss) income from equity method investment-1948851,1244,714
Operating expenses:Interest expense-8,698-4,226-32,905-12,954
Operating expenses:Gain on extinguishment of debt1,4751,475
Operating expenses:IEEPA refund financing costs-2,405-2,405
Operating expenses:Gain (loss) from change in fair value of warrant liability1,171-4998,369-499
Operating expenses:Other income, net3,0952025,011559
Operating expenses:Income (loss) before provision for income taxes-1,5072,071-47,2481,134
Operating expenses:Provision for income taxes4349481,9462,725
Operating expenses:Net income (loss)-1,9411,123-49,194-1,591
Operating expenses:Net income (loss) per share - basic-0.020.01-0.4-0.02
Operating expenses:Net income (loss) per share - diluted-0.020.01-0.4-0.02
Weighted average common shares used in computing income (loss) per share:Basic126,390106,702122,635102,768
Weighted average common shares used in computing income (loss) per share:Diluted126,390108,891122,635102,768

Income Statement

Three Months Ended June 30, — (in thousands)

Three Months Ended June 30, – 2026Three Months Ended June 30, – 2025Twelve Months Ended June 30, – 2026Twelve Months Ended June 30, – 2025
GAAP net income (loss)-1,9411,123-49,194-1,591
Depreciation and amortization (a)2,0251,5987,9426,150
Stock-based compensation1,6802,8186,45510,201
Interest expense, net (b)8,5783,93732,08611,762
Gain on extinguishment of debt-1,475-1,475
Provision for income taxes4349481,9462,725
(Gain) loss from change in fair value of warrant liability-1,171499-8,369499
IEEPA refund financing Costs2,4052,405
Restructuring charges74716,172
Post financing cost1211,152
Adjusted EBITDA12,8789,44810,59528,271

Balance Sheet

(Unaudited) (in thousands)

June 30, – 2026June 30, – 2025
Current assets:Cash and cash equivalents40,62357,416
Current assets:Restricted cash611574
Current assets:Accounts receivable, net67,40983,192
Current assets:Inventories, net147,075141,020
Current assets:Prepaid expenses and other current assets31,78333,501
Current assets:Deferred cost of revenue2761,762
Current assets:Total current assets287,777317,465
Noncurrent assets:Property and equipment, net27,31628,658
Noncurrent assets:Investment in joint venture5,0244,612
Noncurrent assets:Operating lease right-of-use assets27,51233,115
Noncurrent assets:Goodwill57,91157,802
Noncurrent assets:Restricted cash7,5334,144
Noncurrent assets:Other assets30,60324,443
Noncurrent assets:Total assets443,676470,239
Current liabilities:Accounts payable40,55434,033
Current liabilities:Accrued compensation15,66614,573
Current liabilities:Operating lease liabilities, current8,2367,375
Current liabilities:Other accrued liabilities32,23529,361
Current liabilities:Customer advances10,40112,197
Current liabilities:Deferred revenue, current82,81382,306
Current liabilities:Short-term debt, net1,50012,734
Current liabilities:Total current liabilities191,405192,579
Current liabilities:Operating lease liabilities, non-current27,76832,482
Current liabilities:Long-term other liabilities5,4775,160
Current liabilities:Warrant liability2,4278,497
Current liabilities:Deferred revenue, non-current28,53026,566
Current liabilities:Long-term debt, net146,370123,786
Current liabilities:Total liabilities401,977389,070
Stockholders' Equity:Common stock119113
Stockholders' Equity:Additional paid-in capital613,559602,165
Stockholders' Equity:Accumulated other comprehensive loss-3,513-1,837
Stockholders' Equity:Accumulated deficit-568,466-519,272
Stockholders' Equity:Total stockholders’ equity41,69981,169
Stockholders' Equity:Total liabilities and stockholders’ equity443,676470,239
Full release

Statements made in this press release that are not statements of historical fact are forward-looking statements that are subject to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements in this press release relate, but are not limited, to the company's future results of operations and financial position, including expectations regarding: the company’s recently announced financing transaction; the company’s strategic partnerships and collaborations and ability to realize the expected benefits of those relationships; the ability to drive sustainable revenue growth, margin expansion, and long-term shareholder value; the effects of the global macroeconomic conditions on the company’s financial results and business as well as the business of the company’s customers and suppliers; the sufficiency of the company’s cash, cash equivalents and investments to meet the company’s anticipated cash needs for working capital and capital expenditures and the company’s business strategy, plans and objectives; the expected benefits from the transformation plan, including expected improvement in annualized operating profit and cost and margin improvements; the ability to achieve the objectives of the transformation plan; service revenue and service margin improvements; the company’s ability to deliver sustained performance and execute on its strategies and objectives, including related to its transformation efforts and restructuring plans; the company’s ability to improve sales and drive margin expansion; opportunities to accelerate top-line growth and expand profitability; the company’s ability to navigate supply chain, logistics, macroeconomic, and foreign exchange challenges; expectations related to the markets and regions in which the company operates; new product introductions and innovations; installed base growth; clinical outcomes; and the company’s ability to improve execution, drive sustainable, profitable growth, while creating long-term value for patients, providers and shareholders. Forward-looking statements generally can be identified by words such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “may,” “will be,” “will continue,” “will likely result,” and similar expressions. These forward-looking statements involve risks and uncertainties. If any of these risks or uncertainties materialize, or if any of the company’s assumptions prove incorrect, actual results could differ materially from the results expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, risks related to the effect of the global macroeconomic environment on the operations of the company and those of its customers and suppliers; effects related to international tariffs; disruptions to our supply chain, including increased logistics costs; the company's ability to achieve widespread market acceptance of its products; substantial outstanding indebtedness and its ability to maintain compliance with financial covenants related to its debt; the company’s ability to realize the expected benefits of the China joint venture and other strategic partnerships; risks inherent in international operations; geopolitical uncertainty, including armed conflict or political instability in the Middle East or other regions in which the company or its customers operate, and the effect of such conditions on the timing of system installations, customer site readiness, service revenue recognition, and the ability to complete transactions in affected markets; the company's ability to maintain or increase its gross margins on product sales and services; delays in regulatory approvals or the development or release of new offerings; the company's ability to meet the covenants under its credit facilities; the company's ability to convert backlog to revenue; and such other risks identified under the heading “Risk Factors” in the company's Quarterly Report on Form 10-Q, filed with the Securities and Exchange Commission (the “SEC”) on May 6, 2026, and as updated periodically with the company's other filings with the SEC.

Forward-looking statements speak only as of the date the statements are made and are based on information available to the company at the time those statements are made and/or management's good faith belief as of that time with respect to future events. The company assumes no obligation to update forward-looking statements to reflect actual performance or results, changes in assumptions or changes in other factors affecting forward-looking information, except to the extent required by applicable securities laws. Accordingly, investors should not place undue reliance on any forward-looking statements.

###

Financial Tables to Follow

Accuray Incorporated

Condensed Consolidated Statements of Operations

(in thousands, except per share data)

(Unaudited)

Accuray Incorporated

Condensed Consolidated Balance Sheets

(in thousands)

(Unaudited)

Accuray Incorporated

Summary of Orders and Backlog

(in thousands)

(Unaudited)

(a) Book to bill ratio is defined as gross orders for the period divided by product revenue for the period.

Accuray Incorporated

Reconciliation of GAAP Net Income (Loss) to Adjusted Earnings Before Interest, Taxes, Depreciation,

Amortization, Stock-Based Compensation and Other (Adjusted EBITDA)

(in thousands)

(a) Consists of depreciation, primarily on property and equipment, as well as amortization of capitalized software and intangibles.

(b) Consists of interest expense net of interest income.

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Accuray earnings · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.